Stanford Medicine researchers developed a nasal spray vaccine that protected mice against viruses, bacteria and allergens — a ...

JOHANNESBURG (Reuters) -South African biopharmaceutical firm Biovac on Thursday opened a state-of-the-art product development laboratory in Cape Town, backed by the Gates Foundation, to help the ...

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...

Messenger RNA vaccines aren’t just saving human lives—they are protecting elephants as well. In 2024, Tess, an elephant at the Houston Zoo, became the first to receive an mRNA vaccine developed by ...

This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Richard Hatchett, who leads the Cepi, a partnership of governments and philanthropies that was among the first to fund ...